Japanese
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

Fast-track Giant Ventral Hernia Repair

登録ユーザーのみが記事を翻訳できます
ログインサインアップ
リンクがクリップボードに保存されます
状態完了
スポンサー
Bispebjerg Hospital

キーワード

概要

The implementation of an enhanced recovery pathway after giant ventral hernia repair, including preoperative high-dose steroid is examined prospectively and compared with a group of historic controls.

説明

All patients operated on for a large incisional hernia are treated according to the study protocol. Patients are given high-dose glucocorticoid preoperative and the aim is to discharge patients at postoperative day 3.

Morbidity, length of stay, pain, nausea and pulmonary function are among registered outcomes compared with a historic control group.

日付

最終確認済み: 08/31/2015
最初に提出された: 11/10/2014
提出された推定登録数: 11/26/2014
最初の投稿: 12/01/2014
最終更新が送信されました: 09/02/2015
最終更新日: 09/06/2015
実際の研究開始日: 11/30/2014
一次完了予定日: 06/30/2015
研究完了予定日: 06/30/2015

状態または病気

Hernia, Ventral

介入/治療

Other: Fast-track group

段階

-

アームグループ

介入/治療
Fast-track group
Patients treated according to the enhanced recovery pathway. This group is examined prospectively.
Other: Fast-track group
Enhanced recovery after surgery pathway. Postoperatively, a set of well-defined discharge criteria will be assessed daily at 9:00 and 15:00, as well as pain, nausea, time to flatus, saturation and drain production.
Control group
Patients treated according to the historic recovery pathway. This group is examined retrospectively.

適格基準

研究に適格な性別All
サンプリング方法Non-Probability Sample
健康なボランティアを受け入れるはい
基準

Inclusion Criteria:

- Horizontal fascia defect > 10 cm on computed tomography scan

- Planned elective open incisional hernia repair

Exclusion Criteria:

- Known allergy against glucocorticoid treatment

- Insulin-treated diabetes

- Gastric ulcer diagnosed within four weeks preoperative

- Steroid-treated immune disease

- Planned intestinal anastomosis concomitant to hernia repair

結果

主な結果の測定

1. Time to discharge [Participants will be followed for the duration of hospital stay, an expected average of 72 hours]

Time from surgery to discharge [Hours].

二次的な結果の測定

1. Fatigue [Preoperative and for the duration of hospital stay, an expected average of 3 days]

Preoperative and twice daily (9 and 15) postoperative. Measured by a numerical rating scale (1 = No fatigue, 5 = Exhausted).

2. Pain from supine to standing [Preoperative and for the duration of hospital stay, an expected average of 3 days]

Preoperative and twice daily (9 and 15) postoperative. Measured by a numerical rating scale (1 = No pain, 5 = Intolerable pain)

3. Pain when walking 6 meters [Preoperative and for the duration of hospital stay, an expected average of 3 days]

Preoperative and twice daily (9 and 15) postoperative. Measured by a numerical rating scale (1 = No pain, 5 = Intolerable pain)

4. Nausea [Preoperative and for the duration of hospital stay, an expected average of 3 days]

Preoperative and twice daily (9 and 15) postoperative. Measured by a numerical rating scale (1 = No nausea, 5 = Intolerable nausea)

5. Time to bowel function [For the duration of postoperative hospital stay, an expected average of 72 hours]

The time to bowel function [hours] will be registered for each participant

6. Vomiting episodes [Participants will be followed for the duration of hospital stay, an expected average of 3 days]

The daily number of vomiting episodes will be registered for each participant

7. Continuous transcutaneous saturation [From surgery to postoperative day 3 at 12 pm]

Continuous transcutaneous oxygen saturation (percentage), measured by Pulsox 300i (C) (Konica Minolta, Osaka, Japan)

8. C-reactive protein from venous blood sample [Preoperative and for the duration of hospital stay, an expected average of 3 days]

Daily C-reactive protein measured in a venous blood sample.

9. Ear temperature [Preoperative and for the duration of hospital stay, an expected average of 3 days]

Ear temperature (celsius degree) measured daily at 9 and 15.

10. Detailed reason for not being discharged if criteria are otherwise fulfilled [From surgery and for the duration of hospital stay, an expected average of 3 days]

The reason(s) for participants not being discharged if discharge criteria are otherwise fulfilled.

11. Daily wound drain production [From surgery and for the duration of hospital stay, an expected average of 3 days]

Daily registration of the fluid volume [milliliters] in the wound drains postoperative.

Facebookページに参加する

科学に裏打ちされた最も完全な薬草データベース

  • 55の言語で動作します
  • 科学に裏打ちされたハーブ療法
  • 画像によるハーブの認識
  • インタラクティブGPSマップ-場所にハーブをタグ付け(近日公開)
  • 検索に関連する科学出版物を読む
  • それらの効果によって薬草を検索する
  • あなたの興味を整理し、ニュース研究、臨床試験、特許について最新情報を入手してください

症状や病気を入力し、役立つ可能性のあるハーブについて読み、ハーブを入力して、それが使用されている病気や症状を確認します。
*すべての情報は公開された科学的研究に基づいています

Google Play badgeApp Store badge